11GA001 Controlled Trial of “Follow On” Rifaximin

1st December 2012

Body: RFPB

Amount: £111,568.00

People

Photo	Name	Bio
	Professor Robin Spiller	Robin's main interest is in the pathophysiology of functional GI diseases, particularly focusing on the role of infection and inflammation and alterations in serotonin metabolism in the irritable bowel syndrome. He has twice edited the British Society of…